Treatment of Experimental Cerebral Malaria by Slow Release of Artemisone From Injectable Pasty Formulation

Treatment of Experimental Cerebral Malaria by Slow Release of Artemisone From Injectable Pasty Formulation

Malaria caused by Plasmodium falciparum causes numerous cases of morbidity with about 400,000 deaths yearly owing, mainly, to inflammation leading to cerebral malaria (CM). CM conventionally is treated by repetitive administration of anti-plasmodial drugs and supportive non-specific drugs, for about...

Full description

Bibliographic Details
Main Authors: Jacob Golenser, Nadeen Salaymeh, Abd Alroof Higazi, Mohammed Alyan, Mahran Daif, Ron Dzikowski, Abraham J. Domb
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-06-01
Series:Frontiers in Pharmacology
Subjects:
cerebral malaria
artemisone
Plasmodium
slow release
pasty polymer formulation
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.00846/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2020.00846/full

Similar Items